News

Filter

Current filters:

None

64 to 73 of 96126 results

New Gilenya data confirm reducing brain shrinkage matters for people with MS

10-09-2014

Swiss pharma giant Novartis has presented new data at the joint ACTRIMS-ECTRIMS meeting in Boston, USA,…

GilenyaNeurologicalNovartisPharmaceuticalResearch

Positive new data on Boehringer’s nintedanib in IPF patients

10-09-2014

A pre-specified subgroup analysis from the two replicate Phase III INPULSI trials, presented today at…

Boehringer IngelheimnintedanibPharmaceuticalResearchRespiratory and Pulmonary

ReproCELL acquires the iPS Cell Business unit of Stemgent

10-09-2014

Japan-based ReproCELL is to acquire the iPS Cell Business unit of Privately-held US firm Stemgent. This…

BiotechnologyMergers & AcquisitionsReproCELLStemgent

FDA Advisory votes against approving Actavis nebivolol/valsartan combo

FDA Advisory votes against approving Actavis nebivolol/valsartan combo

10-09-2014

Ireland-based generic drug major Actavis yesterday confirmed that the US Food and Drug Administration's…

ActavisCardio-vascularnebivololPharmaceuticalRegulationUSAvalsartan

Oliver Siegel appointed chief operating officer at AFFiRiS

Oliver Siegel appointed chief operating officer at AFFiRiS

09-09-2014

Oliver Siegel has been appointed as chief operating officer at Austrian vaccine specialist AFFiRiS AG,…

AFFiRiSAustriaBoardroomChronic diseasesOliver SiegelPharmaceuticalVaccine specialist

64 to 73 of 96126 results

Back to top